Clinical trial
MR-basierte Charakterisierung Des Knochenmarks in Seiner Bedeutung für Skeletterkrankungen Von Patienten Mit Diabetes
NCT04950283 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MR-basierte Charakterisierung Des Knochenmarks in Seiner Bedeutung für Skeletterkrankungen Von Patienten Mit Diabetes
- Lead sponsor
- University Hospital Tuebingen
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 7, 2021
- Completion date
- December 31, 2024
- Enrollment
- 85 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.